5
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T22062 | CCG-100602 | Rho , Ras | |
CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 μM). | |||
T7764 | CCG-222740 | ROCK , Rho , Ras | |
CCG-222740 is an inhibitor of Rho/MRTF pathway | |||
T68431 | CCG-58150 | ||
CCG-58150 is a potentiInhibitor of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma. | |||
T23296 | (S)-CCG-1423 | Others | |
(S)-CCG-1423 is a stereoisomer of CCG-1423. CCG-1423 is a Rho inhibitor involved in blocking signaling through myocardin-related transcription factor A and serum response factor. | |||
T23221 | (R)-CCG-1423 | Others | |
(R)-CCG-1423 is a stereoisomer of CCG-1423. CCG-1423 is a Rho inhibitor involved in blocking signaling through myocardin-related transcription factor A (MRTF-A) and serum response factor (SRF). |